There simply isnt a standard test for this condition, and any results can be somewhat inaccurate
Cook SF, King AD, van den Anker JN et al , Simultaneous quantification of acetaminophen and five acetaminophen metabolites in human plasma and urine by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry: method validation and application to a neonatal pharmacokinetic study
[8] Retatrutide is the triple-agonist expression of that trajectory, engineered as one peptide that hits GIP, GLP-1, and glucagon receptors simultaneously
Rybelsus is authorised for the treatment of type 2 diabetes, not primarily for weight loss
Back McLean, BA, Wong, CK, Campbell, JE, et al (2021) 'Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation', Endocrine Reviews , 42/2, 101-32
Among these, GLP-1RAs are able to reduce body weight (delaying gastric emptying and increasing satiety) and to reduce blood pressure (through reduction in body weight, but also trough increasing natriuresis and inducing vasodilation), as well as to improve microcirculation perfusion, endothelial function and lipid profile (reducing low-dense-lipoprotein and triglyceride-rich lipoproteins concentrations)
